TSS
RLYB icon

Two Sigma Securities’s Rallybio RLYB Stock Holding History

Two Sigma Securities’s Portfolio RLYB Stock Details RLYB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,894
Closed -$5.12K – 1903
2025
Q2 		$5.12K Buy
+1,894
New +$5.02K ﹤0.01% 1359

Other funds holding RLYB

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return

Two Sigma Securities's RLYB Position: Q3 2025 in Review

Two Sigma Securities sold out of Rallybio (RLYB) in Q3 2025, closing a stake of 1,894 shares — an estimated $5.12K sold.

Two Sigma Securities first reported a position in RLYB in Q2 2025 and held it in 1 quarter. The position peaked at $5.12K in Q2 2025. 45 funds tracked by Wall St. Rank hold RLYB as of Q3 2025.

  • Two Sigma Securities reported no remaining Rallybio position as of Q3 2025 after selling out during the quarter.
  • Two Sigma Securities sold 1,894 Rallybio shares in Q3 2025, an estimated $5.12K.
  • Two Sigma Securities first reported a position in Rallybio in Q2 2025 and held it in 1 quarter.
  • Two Sigma Securities's Rallybio position peaked at $5.12K in Q2 2025.
  • 45 funds tracked by Wall St. Rank held Rallybio as of Q3 2025.

Based on Two Sigma Securities's 13F filing for Q3 2025, filed 14 Nov 2025.